首页 | 官方网站   微博 | 高级检索  
     

间充质干细胞作为载体用于肿瘤治疗
引用本文:徐应龙,王坚.间充质干细胞作为载体用于肿瘤治疗[J].第二军医大学学报,2011,32(9):1030-1035.
作者姓名:徐应龙  王坚
作者单位:广东医学院附属医院泌尿外科,湛江,524000
基金项目:湛江市科技计划项目; 广东医学院附属医院博士科研基金(20401B010010)~~
摘    要:干细胞有无限制自我更新以及分化成多种祖细胞的能力。间充质干细胞(MSCs)能特异地向多种肿瘤以及它们的转移灶迁移,并且它们的迁移是遍及全身的。借助这一特性,基因修饰MSCs可用作特异性靶向药物的载体并表达抗癌因子以抑制肿瘤生长。然而,许多问题和确切的机制尚待解答。本文主要回顾MSCs归巢的机制、MSCs作为载体用于肿瘤治疗以及MSCs与无活性药物载体相比的优缺点。MSCs作为载体可能成为一种细胞治疗,在未来的肿瘤治疗中发挥作用。

关 键 词:间充质干细胞  肿瘤  药物载体  归巢
收稿时间:2011/4/14 0:00:00
修稿时间:2011/6/22 0:00:00

Mesenchymal stem cells: a delivery vehicle for cancer therapy
XU Ying-long and WANG Jian.Mesenchymal stem cells: a delivery vehicle for cancer therapy[J].Academic Journal of Second Military Medical University,2011,32(9):1030-1035.
Authors:XU Ying-long and WANG Jian
Affiliation:Department of Urology, The Affiliated Hospital of Guangdong Medical College, Zhanjiang 524000, Guangdong, China
Abstract:Stem cells possess unlimited self-renewal properties and the ability to produce multiple differentiation progenitors. Mesenchymal stem cells (MSCs) can specifically migrate to multiple kinds of tumors and their metastases in a systemic manner(to all parts of the body). Therefore genetically modified MSCs can serve as vehicle of anticancer factors to inhibit growth of tumor. But many questions remain to be answered and the precise mechanisms remain unclear. This paper reviews the mechanism of MSC homing, MSCs as delivery vectors for cancer therapy and its advantages over traditional drug vehicle. MSCs as delivery vectors can be used for cellular therapy in future cancer treatment.
Keywords:mesenchymal stem cells  neoplasms  drug carriersi  homing
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《第二军医大学学报》浏览原始摘要信息
点击此处可从《第二军医大学学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号